PriceTargets.com logo

Ardent Health - ARDT Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $15.00
  • Forecasted Upside: 69.59%
  • Number of Analysts: 12
  • Breakdown:
  • 2 Sell Ratings
  • 4 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$8.85 As of 12/4/2025 04:59 PM ET
▼ -0.085 (-0.95%)

This chart shows the closing price for ARDT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ardent Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ARDT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ARDT

Analyst Price Target is $15.00
▲ +69.59% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for Ardent Health in the last 3 months. The average price target is $15.00, with a high forecast of $20.00 and a low forecast of $10.00. The average price target represents a 69.59% upside from the last price of $8.85.

This chart shows the closing price for ARDT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 12 polled investment analysts is to hold stock in Ardent Health. This rating changed within the last month from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/13/2024
  • 1 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2024
  • 2 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2024
  • 2 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/10/2025
  • 2 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 2 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/1/2025Weiss RatingsReiterated RatingSell (D) ➝ Sell (D)
11/24/2025JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$15.00 ➝ $12.00
11/18/2025MizuhoLower TargetOutperform ➝ Outperform$20.00 ➝ $13.00
11/18/2025GuggenheimLower TargetBuy ➝ Buy$18.00 ➝ $15.00
11/17/2025Weiss RatingsDowngradeHold (C-) ➝ Sell (D+)
11/17/2025KeyCorpDowngradeOverweight ➝ Sector Weight
11/14/2025Leerink PartnersSet Target$16.00
11/14/2025Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$21.00 ➝ $16.00
11/14/2025Morgan StanleyReiterated RatingOverweight ➝ Equal Weight$22.00 ➝ $12.00
11/14/2025Truist FinancialLower TargetBuy ➝ Buy$21.00 ➝ $13.00
11/14/2025StephensLower TargetOverweight ➝ Overweight$21.00 ➝ $17.00
11/13/2025Bank of AmericaLower TargetUnderperform ➝ Underperform$12.00 ➝ $10.00
10/24/2025Weiss RatingsUpgradeSell (D+) ➝ Hold (C-)
10/14/2025The Goldman Sachs GroupInitiated CoverageNeutral$19.00
10/14/2025The Goldman Sachs GroupInitiated CoverageNeutral$19.00
10/8/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
9/27/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
9/10/2025UBS GroupInitiated CoverageBuy$17.00
8/11/2025JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$18.00 ➝ $15.00
8/7/2025KeyCorpLower TargetOverweight ➝ Overweight$24.00 ➝ $20.00
7/16/2025Bank of AmericaDowngradeNeutral ➝ Underperform$15.50 ➝ $14.60
5/20/2025StephensReiterated RatingOverweight ➝ Overweight$21.00 ➝ $21.00
5/15/2025Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform$21.00 ➝ $21.00
5/9/2025GuggenheimBoost TargetBuy ➝ Buy$16.00 ➝ $18.00
4/9/2025GuggenheimInitiated CoverageBuy$16.00
4/9/2025MizuhoLower TargetOutperform ➝ Outperform$19.00 ➝ $18.00
4/1/2025StephensReiterated RatingOverweight ➝ Overweight$22.00 ➝ $22.00
3/26/2025StephensReiterated RatingOverweight ➝ Overweight$22.00 ➝ $22.00
3/4/2025Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$23.00 ➝ $21.00
2/27/2025StephensReiterated RatingOverweight ➝ Overweight$22.00 ➝ $22.00
1/21/2025Morgan StanleyLower TargetOverweight ➝ Overweight$23.50 ➝ $22.00
1/6/2025Truist FinancialLower TargetBuy ➝ Buy$22.00 ➝ $21.00
12/17/2024JPMorgan Chase & Co.Reiterated RatingNeutral$20.00
11/14/2024Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform$23.00 ➝ $23.00
11/12/2024Leerink PartnersBoost TargetOutperform ➝ Outperform$23.00 ➝ $25.00
11/6/2024Bank of AmericaDowngradeBuy ➝ Neutral$22.00 ➝ $19.00
10/11/2024KeyCorpInitiated CoverageOverweight$24.00
10/10/2024KeyCorpUpgradeStrong-Buy
9/19/2024StephensReiterated RatingOverweight ➝ Overweight$24.00 ➝ $24.00
8/12/2024Leerink PartnrsUpgradeStrong-Buy
8/12/2024Bank of AmericaInitiated CoverageBuy$22.00
8/12/2024Loop CapitalInitiated CoverageBuy ➝ Buy$18.00 ➝ $18.00
8/12/2024StephensInitiated CoverageOverweight ➝ Overweight$24.00 ➝ $24.00
8/12/2024CitigroupInitiated CoverageBuy$21.00
8/12/2024Royal Bank Of CanadaInitiated CoverageOutperform$23.00
8/12/2024Morgan StanleyInitiated CoverageOverweight$27.00
8/12/2024JPMorgan Chase & Co.Initiated CoverageNeutral$18.00
8/12/2024MizuhoInitiated CoverageOutperform$20.00
8/12/2024Leerink PartnersInitiated CoverageOutperform$23.00
8/12/2024Truist FinancialInitiated CoverageBuy ➝ Buy$21.00 ➝ $21.00
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.53 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 12 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 12 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 7 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 8 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 16 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 13 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 4 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 20 very positive mentions
  • 48 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 20 very positive mentions
  • 48 positive mentions
  • 5 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Ardent Health logo
Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
Read More

Today's Range

Now: $8.85
Low: $8.75
High: $8.94

50 Day Range

MA: $12.60
Low: $8.31
High: $15.23

52 Week Range

Now: $8.85
Low: $8.28
High: $17.34

Volume

470,562 shs

Average Volume

791,173 shs

Market Capitalization

$1.27 billion

P/E Ratio

6.10

Dividend Yield

N/A

Beta

0.77

Frequently Asked Questions

What sell-side analysts currently cover shares of Ardent Health?

The following sell-side analysts have issued reports on Ardent Health in the last year: Bank of America Corporation, Guggenheim, JPMorgan Chase & Co., KeyCorp, Leerink Partners, Mizuho, Morgan Stanley, Royal Bank Of Canada, Stephens, The Goldman Sachs Group, Inc., Truist Financial Corporation, UBS Group AG, Wall Street Zen, and Weiss Ratings.
View the latest analyst ratings for ARDT.

What is the current price target for Ardent Health?

0 Wall Street analysts have set twelve-month price targets for Ardent Health in the last year. Their average twelve-month price target is $15.00, suggesting a possible upside of 69.6%. KeyCorp has the highest price target set, predicting ARDT will reach $20.00 in the next twelve months. Bank of America Corporation has the lowest price target set, forecasting a price of $10.00 for Ardent Health in the next year.
View the latest price targets for ARDT.

What is the current consensus analyst rating for Ardent Health?

Ardent Health currently has 2 sell ratings, 4 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ARDT, but not buy more shares or sell existing shares.
View the latest ratings for ARDT.

What other companies compete with Ardent Health?

Other companies that are similar to Ardent Health include Sotera Health, Option Care Health, GeneDx, Celcuity and GRAIL. Learn More about companies similar to Ardent Health.

How do I contact Ardent Health's investor relations team?

Ardent Health's physical mailing address is ONE BURTON HILLS BLVD, SUITE 250, NASHVILLE, TN, 37215. The company's listed phone number is (615) 296-3000 and its investor relations email address is [email protected]. The official website for Ardent Health is ardenthealth.com. Learn More about contacing Ardent Health investor relations.